{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T12:34:33Z","timestamp":1722515673200},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,11]]},"DOI":"10.7759\/cureus.36028","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T23:07:47Z","timestamp":1678576067000},"source":"Crossref","is-referenced-by-count":1,"title":["Antithyroid Drugs in the Management of Graves' Disease: A Friend and Foe"],"prefix":"10.7759","author":[{"given":"Muhammad I","family":"Butt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Riazuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal","family":"Joueidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najeeb","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1430639","article-title":"Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT)","volume":"143","author":"Bjoro T","year":"2000","unstructured":"Bjoro T, Holmen J, Kr\u00fcger O, et al.. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). Eur J Endocrinol. 2000, 143:639-47. 10.1530\/eje.0.1430639","journal-title":"Eur J Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2004.14.926","article-title":"Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees","volume":"14","author":"Reiners C","year":"2004","unstructured":"Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R, Schumm-Draeger PM. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid. 2004, 14:926-32. 10.1089\/thy.2004.14.926","journal-title":"Thyroid"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2409","article-title":"The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis","volume":"99","author":"Garmendia Madariaga A","year":"2014","unstructured":"Garmendia Madariaga A, Santos Palacios S, Guill\u00e9n-Grima F, Galofr\u00e9 JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014, 99:923-31. 10.1210\/jc.2013-2409","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves' hyperthyroidism","volume":"7","author":"Kahaly GJ","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH. 2018 European Thyroid Association guideline for the management of Graves' hyperthyroidism. Eur Thyroid J. 2018, 7:167-86. 10.1159\/000490384","journal-title":"Eur Thyroid J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.12.015","article-title":"Hyperthyroidism induces apoptosis in rat liver through activation of death receptor-mediated pathways","volume":"46","author":"Kumar A","year":"2007","unstructured":"Kumar A, Sinha RA, Tiwari M, et al.. Hyperthyroidism induces apoptosis in rat liver through activation of death receptor-mediated pathways. J Hepatol. 2007, 46:888-98. 10.1016\/j.jhep.2006.12.015","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0045","article-title":"Analysis of antithyroid drug-induced severe liver injury in 18,558 newly diagnosed patients with Graves' disease in Japan","volume":"29","author":"Suzuki N","year":"2019","unstructured":"Suzuki N, Noh JY, Hiruma M, et al.. Analysis of antithyroid drug-induced severe liver injury in 18,558 newly diagnosed patients with Graves' disease in Japan. Thyroid. 2019, 29:1390-8. 10.1089\/thy.2019.0045","journal-title":"Thyroid"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jat.2731","article-title":"Th2 cytokine-mediated methimazole-induced acute liver injury in mice","volume":"32","author":"Kobayashi M","year":"2012","unstructured":"Kobayashi M, Higuchi S, Ide M, Nishikawa S, Fukami T, Nakajima M, Yokoi T. Th2 cytokine-mediated methimazole-induced acute liver injury in mice. J Appl Toxicol. 2012, 32:823-33. 10.1002\/jat.2731","journal-title":"J Appl Toxicol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5681\/apb.2015.001","article-title":"An overview on the proposed mechanisms of antithyroid drugs-induced liver injury","volume":"5","author":"Heidari R","year":"2015","unstructured":"Heidari R, Niknahad H, Jamshidzadeh A, Eghbal MA, Abdoli N. An overview on the proposed mechanisms of antithyroid drugs-induced liver injury. Adv Pharm Bull. 2015, 5:1-11. 10.5681\/apb.2015.001","journal-title":"Adv Pharm Bull"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.675","article-title":"The thyroid immunology of the postpartum period","volume":"9","author":"Davies TF","year":"1999","unstructured":"Davies TF. The thyroid immunology of the postpartum period. Thyroid. 1999, 9:675-84. 10.1089\/thy.1999.9.675","journal-title":"Thyroid"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study","volume":"78","author":"Wang MT","year":"2014","unstructured":"Wang MT, Lee WJ, Huang TY, Chu CL, Hsieh CH. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study. Br J Clin Pharmacol. 2014, 78:619-29. 10.1111\/bcp.12336","journal-title":"Br J Clin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-22-0030","article-title":"Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade","volume":"11","author":"Brancatella A","year":"2022","unstructured":"Brancatella A, Pierotti L, Viola N, et al.. Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade. Eur Thyroid J. 2022, 11:e220030. 10.1530\/ETJ-22-0030","journal-title":"Eur Thyroid J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2020.11.007","article-title":"Clinical case report: dissociation of clinical course of coexisting autoimmune hepatitis and Graves disease","volume":"7","author":"Patel AM","year":"2021","unstructured":"Patel AM, Stanback C, Vellanki P. Clinical case report: dissociation of clinical course of coexisting autoimmune hepatitis and Graves disease. AACE Clin Case Rep. 2021, 7:36-9. 10.1016\/j.aace.2020.11.007","journal-title":"AACE Clin Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0194599819829052","article-title":"Effects of preoperative iodine administration on thyroidectomy for hyperthyroidism: a systematic review and meta-analysis","volume":"160","author":"Tsai CH","year":"2019","unstructured":"Tsai CH, Yang PS, Lee JJ, Liu TP, Kuo CY, Cheng SP. Effects of preoperative iodine administration on thyroidectomy for hyperthyroidism: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2019, 160:993-1002. 10.1177\/0194599819829052","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2016177","article-title":"Cholestyramine as monotherapy for Graves' hyperthyroidism","volume":"57","author":"Er C","year":"2016","unstructured":"Er C, Sule AA. Cholestyramine as monotherapy for Graves' hyperthyroidism. Singapore Med J. 2016, 57:644-5. 10.11622\/smedj.2016177","journal-title":"Singapore Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02249.x","article-title":"The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism","volume":"62","author":"Tsai WC","year":"2005","unstructured":"Tsai WC, Pei D, Wang TF, et al.. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism. Clin Endocrinol (Oxf). 2005, 62:521-4. 10.1111\/j.1365-2265.2005.02249.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-008-9107-5","article-title":"Low doses of cholestyramine in the treatment of hyperthyroidism","volume":"34","author":"Kaykhaei MA","year":"2008","unstructured":"Kaykhaei MA, Shams M, Sadegholvad A, Dabbaghmanesh MH, Omrani GR. Low doses of cholestyramine in the treatment of hyperthyroidism. Endocrine. 2008, 34:52-5. 10.1007\/s12020-008-9107-5","journal-title":"Endocrine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0994","article-title":"Management of neonates born to women with Graves' disease: a cohort study","volume":"170","author":"Besan\u00e7on A","year":"2014","unstructured":"Besan\u00e7on A, Beltrand J, Le Gac I, Luton D, Polak M. Management of neonates born to women with Graves' disease: a cohort study. Eur J Endocrinol. 2014, 170:855-62. 10.1530\/EJE-13-0994","journal-title":"Eur J Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.20344\/amp.12279","article-title":"Neonates born to mothers with Graves' disease: 15 year experience of a pediatric endocrinology department","volume":"33","author":"Luz IR","year":"2020","unstructured":"Luz IR, Martins JR, Jer\u00f3nimo M, Caetano JS, Cardoso R, Dinis I, Mirante A. Neonates born to mothers with Graves' disease: 15 year experience of a pediatric endocrinology department. Acta Med Port. 2020, 33:483-90. 10.20344\/amp.12279","journal-title":"Acta Med Port"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/138056-antithyroid-drugs-in-the-management-of-graves-disease-a-friend-and-foe","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:56:03Z","timestamp":1707508563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/138056-antithyroid-drugs-in-the-management-of-graves-disease-a-friend-and-foe"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,11]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.36028","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,11]]}}}